Skip directly to Accessibility Notice

PPH
VanEck Pharmaceutical ETF

Fund Description

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS®US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 09/23/21

  • 30-Day SEC Yield1

    1.64%
  • Total Net Assets

    $323.9M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Quarterly